{
    "2020-11-08": [
        [
            {
                "time": "",
                "original_text": "Biontech首席执行官Ugur Sahin：如mRNA新冠疫苗结果好，我们产量能达3000万剂",
                "features": {
                    "keywords": [
                        "Biontech",
                        "mRNA",
                        "新冠疫苗",
                        "产量",
                        "3000万剂"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "冠脉支架集采落地，医疗耗材利空压制释放【东吴医药朱国广团队|1106周报】",
                "features": {
                    "keywords": [
                        "冠脉支架",
                        "集采",
                        "医疗耗材",
                        "利空",
                        "压制释放"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "热门融资标的股票分析",
                "features": {
                    "keywords": [
                        "热门融资",
                        "标的股票",
                        "分析"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|周报】估值持续回落，重点推荐有望进入业绩加速期的CDMO",
                "features": {
                    "keywords": [
                        "浙商医药",
                        "估值回落",
                        "业绩加速期",
                        "CDMO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CDMO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}